Biotech Co. Shareholders To Pay $3M To End SEC Fraud Suit
By MJ Koo ( October 18, 2023, 8:41 PM EDT) -- An ex-executive of RenovaCare and a shareholder have agreed to pay about $3 million to settle a U.S. Securities and Exchange Commission suit accusing them of artificially inflating the stock price of the biotech company....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.